Search

everythinglearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells can cause alopecia areata by themselves.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Interleukin-1 increases keratin K6 production in skin cells.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

The research found that the molecule lncRNA-H19 helps hair follicle cells grow by affecting certain cell pathways in cashmere goats.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

RANKL causes lymph nodes to grow by making certain cells multiply.

Blocking LFA-1 prevents hair loss in mice.

IL-1β inhibits human hair follicle growth.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.